These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. In vitro activity of ticarcillin plus clavulanic acid (BRL 28500, 'Timentin') against ticarcillin-resistant gram-negative rods. Chattopadhyay B, Hall I. Curr Med Res Opin; 1984; 9(3):157-60. PubMed ID: 6568146 [Abstract] [Full Text] [Related]
28. Effect of ticarcillin and ticarcillin/clavulanic acid on the in-vitro activity of human granulocytes against beta-lactamase-producing Klebsiella pneumoniae. Cuffini AM, de Renzi G, Tullio V, Paizis G, Carlone NA. Int J Tissue React; 1995 Mar; 17(5-6):199-203. PubMed ID: 8835630 [Abstract] [Full Text] [Related]
30. Discrepancies between disk diffusion and broth susceptibility studies of the activity of ticarcillin plus clavulanic acid against ticarcillin-resistant Pseudomonas aeruginosa. Manian FA, Alford RH. Antimicrob Agents Chemother; 1986 Jul; 30(1):35-8. PubMed ID: 3092732 [Abstract] [Full Text] [Related]
33. Development of beta-lactamase inhibitors. Sutherland R. J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512 [Abstract] [Full Text] [Related]
34. Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers. Appelbaum PC, Spangler SK, Jacobs MR. Antimicrob Agents Chemother; 1990 Aug; 34(8):1546-50. PubMed ID: 2221864 [Abstract] [Full Text] [Related]
35. Efficacy of clavulanate-potentiated antibiotics against Bacteroides species and artificially associated cultures of aerobes and anaerobes. Werner H, Heizmann WR, Freuer G, Mitinis N, Heilmann F. J Antimicrob Chemother; 1989 Nov; 24 Suppl B():55-61. PubMed ID: 2606820 [Abstract] [Full Text] [Related]
36. Antistaphylococcal activity of amoxicillin and ticarcillin when combined with clavulanic acid. Evaluation of oxacillin-resistant and oxacillin-susceptible isolates. Barry AL. Diagn Microbiol Infect Dis; 1990 Nov; 13(5):357-61. PubMed ID: 2282775 [Abstract] [Full Text] [Related]
37. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres. Jacobs MR, Spangler SK, Appelbaum PC. J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827 [Abstract] [Full Text] [Related]
38. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors. Qadri SM, Ueno Y, Cunha BA. Chemotherapy; 1996 Sep; 42(5):334-42. PubMed ID: 8874972 [Abstract] [Full Text] [Related]
39. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium]. Leclercq R, Duval J. Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109 [Abstract] [Full Text] [Related]
40. A comparison of agar dilution, identification of beta-lactamases and disc diffusion methods for assessing the sensitivity to ticarcillin-clavulanic acid. Joly B, Chanal M, Sirot D, Cluzel M, Sirot J, Cluzel R. J Antimicrob Chemother; 1986 May; 17 Suppl C():27-33. PubMed ID: 3522530 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]